PGI23 - COST-EFFECTIVENESS ANALYSIS OF PARENTERAL METHOTREXATE FOR THE TREATMENT OF CROHN’S DISEASE IN THE CZECH REPUBLIC

Value in Health ◽

10.1016/j.jval.2018.09.865 ◽

2018 ◽

Vol 21 ◽

pp. S145

Author(s):

T. Mlcoch ◽

B. Hajickova ◽

E. Ornstová ◽

K. Chadimova ◽

J. Bartakova ◽

...

Keyword(s):

Crohn’S Disease ◽

Czech Republic ◽

Cost Effectiveness ◽

Crohn's Disease ◽

Cost Effectiveness Analysis ◽

The Czech Republic ◽

Effectiveness Analysis

Download Full-text

PGI21 - COST-EFFECTIVENESS ANALYSIS OF USTEKINUMAB VERSUS ADALIMUMAB, INFLIXIMAB AND VEDOLIZUMAB FOR THE TREATMENT OF PATIENTS WITH MODERATELY TO SEVERE ACTIVE CROHN’S DISEASE FOR TURKEY

Value in Health ◽

10.1016/j.jval.2018.09.863 ◽

2018 ◽

Vol 21 ◽

pp. S145

Author(s):

M. Arhan ◽

H.A. Tezel ◽

M. Toruner ◽

B. Bilaloğlu ◽

S. Koral ◽

...

Keyword(s):

Crohn’S Disease ◽

Cost Effectiveness ◽

Crohn's Disease ◽

Cost Effectiveness Analysis ◽

Effectiveness Analysis

Download Full-text

Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD—A Cost-Effectiveness Analysis in the Czech Republic

Value in Health Regional Issues ◽

10.1016/j.vhri.2018.09.002 ◽

2018 ◽

Vol 16 ◽

pp. 112-118 ◽

Author(s):

Jana Skoupa ◽

Viktor Kasak ◽

Jiri Klimes ◽

Tomas Valena

Keyword(s):

Czech Republic ◽

Cost Effectiveness ◽

Cost Effectiveness Analysis ◽

The Czech Republic ◽

Effectiveness Analysis

Download Full-text

Proactive therapeutic drug monitoring of adalimumab for pediatric Crohn's disease patients‐A Cost‐effectiveness analysis

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.15373 ◽

2020 ◽

Author(s):

Jiaqi Yao ◽

Xinchan Jiang ◽

Joyce H.S. You

Keyword(s):

Crohn’S Disease ◽

Cost Effectiveness ◽

Therapeutic Drug Monitoring ◽

Crohn's Disease ◽

Drug Monitoring ◽

Cost Effectiveness Analysis ◽

Therapeutic Drug ◽

Effectiveness Analysis

Download Full-text

A Cost-Effectiveness Analysis Evaluating the Role of Fecal Calprotectin for Postoperative Surveillance after Surgical Resection for Crohn’s Disease

Gastroenterology ◽

10.1016/s0016-5085(17)32116-9 ◽

2017 ◽

Vol 152 (5) ◽

pp. S589

Author(s):

Gaurav Ghosh ◽

Yecheskel Schneider ◽

Nicole T. Shen ◽

Monica Saumoy ◽

Shirley A. Cohen-Mekelburg ◽

...

Keyword(s):

Crohn’S Disease ◽

Cost Effectiveness ◽

Crohn's Disease ◽

Surgical Resection ◽

Fecal Calprotectin ◽

Cost Effectiveness Analysis ◽

Postoperative Surveillance ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Ginkgo Biloba Extract (Egb761® - Tanakan®) for The Treatment of Dementia In The Czech Republic

Value in Health ◽

10.1016/j.jval.2015.09.2462 ◽

2015 ◽

Vol 18 (7) ◽

pp. A756

Author(s):

K Kruntoradova ◽

M Mandelikova ◽

T Mlcoch ◽

T Dolezal

Keyword(s):

Czech Republic ◽

Cost Effectiveness ◽

Ginkgo Biloba ◽

Ginkgo Biloba Extract ◽

Cost Effectiveness Analysis ◽

The Czech Republic ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease

The European Journal of Health Economics ◽

10.1007/s10198-012-0430-7 ◽

2012 ◽

Vol 14 (6) ◽

pp. 853-861 ◽

Author(s):

Monia Marchetti ◽

Nicola L. Liberato ◽

Antonio Di Sabatino ◽

Gino R. Corazza

Keyword(s):

Crohn’S Disease ◽

Cost Effectiveness ◽

Crohn's Disease ◽

Cost Effectiveness Analysis ◽

Newly Diagnosed ◽

Top Down ◽

Effectiveness Analysis

Download Full-text

Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2007.03548.x ◽

2007 ◽

Vol 26 (11-12) ◽

pp. 1509-1520 ◽

Author(s):

G. G. KAPLAN ◽

C. HUR ◽

J. KORZENIK ◽

B. E. SANDS

Keyword(s):

Crohn’S Disease ◽

Cost Effectiveness ◽

Crohn's Disease ◽

Dose Escalation ◽

Cost Effectiveness Analysis ◽

Loss Of Response ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Tacrolimus As Primary Immunosuppression For Lung Transplant Recipients In The Czech Republic

Value in Health ◽

10.1016/j.jval.2017.08.1489 ◽

2017 ◽

Vol 20 (9) ◽

pp. A645

Author(s):

K Lamblova ◽

T Mlcoch ◽

E Ornstova ◽

T Dolezal

Keyword(s):

Czech Republic ◽

Cost Effectiveness ◽

Lung Transplant ◽

Cost Effectiveness Analysis ◽

Transplant Recipients ◽

The Czech Republic ◽

Effectiveness Analysis ◽

Lung Transplant Recipients

Download Full-text

PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN: A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC

Value in Health ◽

10.1016/j.jval.2018.09.779 ◽

2018 ◽

Vol 21 ◽

pp. S130-S131

Author(s):

M. Russel-Szymczyk ◽

W. Parekh ◽

K. Rychna ◽

J. Pöhlmann ◽

B. Hunt

Keyword(s):

Type 2 Diabetes ◽

Czech Republic ◽

Cost Effectiveness ◽

Basal Insulin ◽

Cost Effectiveness Analysis ◽

The Czech Republic ◽

Effectiveness Analysis

Download Full-text

Cost-Effectiveness Analysis of Secukinumab Compared to Ustekinumab In The Treatment of Moderate to Severe Plaque Psoriasis In The Czech Republic

Value in Health ◽

10.1016/j.jval.2015.09.575 ◽

2015 ◽

Vol 18 (7) ◽

pp. A424 ◽

Author(s):

J Klimes ◽

P Mollon ◽

C Graham ◽

J Rajnoch ◽

F Dostal ◽

...

Keyword(s):

Czech Republic ◽

Cost Effectiveness ◽

Plaque Psoriasis ◽

Cost Effectiveness Analysis ◽

The Czech Republic ◽

Severe Plaque Psoriasis ◽

Effectiveness Analysis

Download Full-text